Walgreens and VillageMD, a leading national provider of primary care, today announced a collaboration focused on providing adult patients in the Houston community with a transformative primary care experience.
VillageMD will operate state-of-the-art primary care clinics next to five Walgreens stores in the Houston area, with the first locations scheduled to open by the end of 2019. The conveniently located clinics, branded ˜Village Medical at Walgreens, will provide comprehensive primary care services, integrated tightly with pharmacists, nurses and social workers to meet the full suite of patient needs. The clinics will be comprised of 2,500 square feet to serve the full adult continuum, including seniors.
The two companies continue to explore expansion of ˜Village Medical at Walgreens primary care clinics in Houston and other markets.
Village Medical at Walgreens patients will benefit from VillageMDs patent-pending docOS system, which integrates data and technology to give patients the best care possible with a 360-degree view of their health needs. docOS identifies missing diagnoses and gaps in health, allowing doctors and patients to better manage the chronic conditions that impede health and drive costs in the healthcare system. The advanced technology includes an easy and convenient check in either by phone or a kiosk, home-based monitoring, and tele-medicine.
This collaboration with VillageMD demonstrates our ongoing commitment to create neighborhood health destinations that bring affordable health care services to customers and provide a differentiated patient experience to the communities we serve, said Pat Carroll, M.D., Walgreens chief medical officer and group vice president, healthcare services and clinical programs.
VillageMD has a strong track record nationally of improving outcomes and reducing the cost of healthcare through their transformative primary care model. With more than 120 primary care physicians in their medical group in Houston, we look forward to working with them as we focus on the health and well-being of the community, added Carroll.
The integration of primary care and pharmacy is yet another example of the value-based commitment that Walgreens and VillageMD demonstrate to customers, patients and the broader healthcare landscape, said Tim Barry, CEO of VillageMD. We are honored to collaborate with such a trusted partner in the lives of so many Americans.
VillageMD is a leading provider of health care for organizations moving toward a primary care-led, high-value clinical model. The VillageMD solution provides the tools, technology, operations, and staffing support needed for physicians to drive the highest quality clinical results across a population. VillageMD works with physician groups, independent practice associations, and health systems to improve quality, deliver a first-rate patient experience, and lower costs in the communities they serve. It has grown to include more than 2,500 physicians across eight markets, and is responsible for approximately 500,000 lives and $2.8 billion in healthcare spending. www.villageMD.com
Walgreens (walgreens.com), one of the nation’s largest drugstore chains, is included in the Retail Pharmacy USA Division of Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the first global pharmacy-led, health and wellbeing enterprise. Approximately 8 million customers interact with Walgreens in stores and online each day, using the most convenient, multichannel access to consumer goods and services and trusted, cost-effective pharmacy, health and wellness services and advice. As of August 31, 2018, Walgreens operates 9,560 drugstores with a presence in all 50 states, the District of Columbia, Puerto Rico and the U.S. Virgin Islands, along with its omnichannel business, Walgreens.com. Approximately 400 Walgreens stores offer Healthcare Clinic or other provider retail clinic services.
Cautionary Note Regarding Forward-Looking Statements. All statements in this release that are not historical are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are not guarantees of future performance and involve risks, assumptions and uncertainties, including, but not limited to, those related to the timing and effectiveness of collaboration plans, the ability of to realize the anticipated benefits of the collaboration, any potential future expansion of the collaboration, and the ability to achieve anticipated financial and operating results in the amounts and at the times anticipated, as well as those described in Item 1A (Risk Factors) of Walgreens Boots Alliance, Inc.s Form 10-K for its fiscal year ending August 31, 2018, and subsequent documents that Walgreens Boots Alliance, Inc. files or furnishes with the Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially. These forward-looking statements speak only as of the date they are made. Except to the extent required by law, Walgreens Boots Alliance, Inc. does not undertake, and expressly disclaims, any duty or obligation to update publicly any forward-looking statement after the date of this release, whether as a result of new information, future events, changes in assumptions or otherwise.
Scott Goldberg, Walgreens; 847-315-7649; [email protected]
Lynch, Lynch Communications Group for VillageMD; 773-505-9719; [email protected]